Bob Swanson, the founder of Genentech, embodied virtues that today's venture capitalists are badly in need of.
After a decade of disappointment and a teenager's death, this experimental treatment faces a crucial test. Can it cure hemophilia?
DNA is Wall Street's latest craze.
Minuscule "smart bombs" that find cancer cells, kill them with the help of lasers and report the kills. Sound crazy? Guess again. That treatment scenario may be less than a decade away.